Cargando…

Neuroprotective effects of PPARα in retinopathy of type 1 diabetes

Diabetic retinopathy (DR) is a common neurovascular complication of type 1 diabetes. Current therapeutics target neovascularization characteristic of end-stage disease, but are associated with significant adverse effects. Targeting early events of DR such as neurodegeneration may lead to safer and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearsall, Elizabeth A., Cheng, Rui, Matsuzaki, Satoshi, Zhou, Kelu, Ding, Lexi, Ahn, Bumsoo, Kinter, Michael, Humphries, Kenneth M., Quiambao, Alexander B., Farjo, Rafal A., Ma, Jian-xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361421/ https://www.ncbi.nlm.nih.gov/pubmed/30716067 http://dx.doi.org/10.1371/journal.pone.0208399

Ejemplares similares

PPARα is essential for retinal lipid metabolism and neuronal survival
por: Pearsall, Elizabeth A., et al.
Publicado: (2017)

The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular Dysfunction
por: Yuan, Tian, et al.
Publicado: (2022)

Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy
por: Vanlandingham, Phillip A., et al.
Publicado: (2017)

Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
por: Chen, Qian, et al.
Publicado: (2017)

DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice
por: Zhu, Ying, et al.
Publicado: (2021)

Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis
por: Cheng, Rui, et al.
Publicado: (2016)

Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease
por: Coursey, Terry G, et al.
Publicado: (2018)

PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020)

Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes
por: Matlock, H. Greg, et al.
Publicado: (2020)

Insulin signaling alters antioxidant capacity in the diabetic heart
por: Matsuzaki, Satoshi, et al.
Publicado: (2021)

Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
por: Farjo, Rafal, et al.
Publicado: (2006)

Mitochondrial respiration and redox coupling in articular chondrocytes
por: Lane, Rachel S, et al.
Publicado: (2015)

Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration
por: Qiu, Fangfang, et al.
Publicado: (2017)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013)

PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
por: Pérez-Segura, Isaac, et al.
Publicado: (2023)

Oleuropein Promotes Neural Plasticity and Neuroprotection via PPARα-Dependent and Independent Pathways
por: Malliou, Foteini, et al.
Publicado: (2023)

Modulation of cGAS-STING signaling by PPARα in a mouse model of ischemia-induced retinopathy
por: Ma, Xiang, et al.
Publicado: (2022)

Myocardial Hypertrophy and Compensatory Increase in Systolic Function in a Mouse Model of Oxidative Stress
por: Varshney, Rohan, et al.
Publicado: (2021)

Neurodegeneration and Neuroprotection in Diabetic Retinopathy
por: Ola, Mohammad Shamsul, et al.
Publicado: (2013)

Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy
por: Qu, Qiang, et al.
Publicado: (2022)

Retention of function without normal disc morphogenesis occurs in cone but not rod photoreceptors
por: Farjo, Rafal, et al.
Publicado: (2006)

Fasudil mediates neuroprotection in ischemia/reperfusion by modulating the ROCK-PPARα-NOX axis
por: Yang, Xitong, et al.
Publicado: (2023)

Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice
por: Pharaoh, Gavin, et al.
Publicado: (2019)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

Cardiac Insulin Signaling Regulates Glycolysis Through Phosphofructokinase 2 Content and Activity
por: Bockus, Lee B., et al.
Publicado: (2017)

Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
por: Lee, Kyungwon, et al.
Publicado: (2012)

Increased cardiac PFK-2 protects against high-fat diet-induced cardiomyopathy and mediates beneficial systemic metabolic effects
por: Mendez Garcia, Maria F., et al.
Publicado: (2023)

PPARα and Effects of TCE
por: Klaunig, James E., et al.
Publicado: (2007)

Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy
por: Wang, Nan, et al.
Publicado: (2022)

Metabolomics of the interaction between PPAR-α and age in the PPAR-α-null mouse
por: Atherton, Helen J, et al.
Publicado: (2009)

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
por: Hernández, Cristina, et al.
Publicado: (2016)

Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching
por: Ahn, Bumsoo, et al.
Publicado: (2019)

The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy
por: Treacy, Maxwell P, et al.
Publicado: (2012)

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012)

The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
por: Swanson, Christine R, et al.
Publicado: (2011)

The loss of cardiac SIRT3 decreases metabolic flexibility and proteostasis in an age-dependent manner
por: Li, Ping, et al.
Publicado: (2022)

Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy
por: Deng, Guotao, et al.
Publicado: (2017)

An Ideal PPAR Response Element Bound to and Activated by PPARα
por: Tzeng, John, et al.
Publicado: (2015)

Molecular investigation of candidate genes for pyroptosis-induced inflammation in diabetic retinopathy
por: Wang, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kf0hu1i5rno784lvka6r6bka0t